Zydus Lifesciences arm gets USFDA nod to market generic Levomilnacipran ER capsules

The tentative approval granted by the US Food and Drug Administration (USFDA) to Zydus Pharmaceuticals (USA) Inc is to market Levomilnacipran extended-release capsules of strengths 20 mg, 40 mg, 80 mg, and 120 mg, the company said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/r2hnBfx